Trial Profile
Usefulness of Low-dose Pimobendan for Patients with Chronic Heart Failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2013
Price :
$35
*
At a glance
- Drugs Pimobendan (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms LDP-CHF
- 22 Jan 2013 New trial record